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Aside from its role in cell membrane integrity, cholesterol is a key component in steroid hormone production. The vital
functions of steroid hormones such as estrogen, testosterone, glucocorticoids (Gcrts) and mineralocorticoids (Mnrts) in
perinatal and adult life are well understood; however, their role during early embryonic development remains largely
unexplored. Here we show that siRNA-mediated perturbation of steroid hormone production during mesoderm formation has
important consequences on cardiac differentiation in mouse embryonic stem cells (mESC). Both Gcrts and Mnrts are capable of
driving cardiac differentiation in mESC. Interestingly, the Gcrt receptor is widely expressed during gastrulation in the mouse,
and is exclusively localized in the nuclei—and thus active—in visceral endoderm cells, suggesting that it functions much earlier
than previously anticipated. We therefore studied Gcrt signaling in mESC as a model of the gastrulating embryo, and found that
Gcrt signaling regulates expression of the transcription factor Hnf4a and the secreted Nodal and BMP inhibitor Cer1 in the early
visceral endoderm. RNAi-mediated knockdown of Gcrt function blocked cardiomyocyte differentiation, with limited effects on
other cardiovascular cell types including vascular endothelial cells and smooth muscle. Furthermore, the cardiogenic effect of
Gcrts required Hnf4a and paracrine Cer1. These results establish a novel function for cholesterol-derived steroid hormones and
identify Gcrt signaling in visceral endoderm cells as a regulator of Cer1 and cardiac fate.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).⁎ Corresponding author at: Sanford Burnham Medical Research
Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
E-mail address: ewillems@sanfordburnham.org (E. Willems).
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1873-5061/© 2015 The Authors. Published by Elsevier B.V. This
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Cholesterol is an essential structural component of the cell
membrane and is needed for cell shape and motility.
Cholesterol is also an important source for the productionis an open access article under the CC BY-NC-ND license
89Glucocorticoids control cell fateof steroid hormones such as the glucocorticoids (Gcrt),
mineralocorticoids (Mnrt), estrogen and testosterone, which
are produced by a series of cytochrome class enzymes (Han
et al., 2014). Interestingly, very little is known about the
function of cholesterol derivatives during early mammalian
development, despite the fact that the two cholesterol
modifying enzymes Cyp11a1 and Cyp17a1 are prominently
expressed and active in the visceral endoderm of gastrulating
mouse embryos (Bair and Mellon, 2004; Korgun et al., 2003).
Moreover, Cyp17a1 is essential for early development since
deletion of the Cyp17a1 gene in the mouse results in death by
embryonic day 7 (Bair andMellon, 2004). In addition,mRNA for
the receptor Nr3c1 of the cholesterol-derived Gcrt is enriched
in the endoderm of the rat embryo (Korgun et al., 2003). Gcrts
comprise a class of steroid hormones that are important for
adult life (Kadmiel and Cidlowski, 2013; Newton, 2000).
Synthetized in the adrenal cortex of adults, Gcrts reach most
organs through the bloodstream. Once within cells, Gcrts bind
to the nuclear receptor Nr3c1, causing receptor dimerization
and translocation to the nucleus, where the ligand–receptor
complex interacts with Gcrt response elements in the
promoters of Gcrt target genes (Kadmiel and Cidlowski,
2013; Newton, 2000). Functionally, Gcrts are best known for
maintaining glucose levels in adults, thereby providing a
steady supply of ATP and pyruvate, both essential energy
components for the cell. Gcrts are also important repressors of
inflammation through a negative feedback loop of the immune
system (Kadmiel and Cidlowski, 2013; Newton, 2000). Very
little is known about Gcrt function during early mammalian
embryonic development, and to our knowledge, a role in cell
fate specification is unexplored.
Here, we show that cholesterol metabolites play an
important role in cardiac differentiation in mouse embryonic
stem cells (mESC). Gcrt receptor expression in the early
mouse embryo and its exclusive localization to cell nuclei
within the visceral endoderm then prompted us to further
investigate a possible role for this class of cholesterol-
derived steroid hormones. As the visceral endoderm is an
important signaling center for the formation of anterior
structures including head and heart (Arai et al., 1997;
Perea-Gomez et al., 2002), we studied Gcrt function in
differentiating mESC as an in vitro model of the developing
mouse embryo. We found that Gcrt controls expression of
Cerberus-1 (Cer1), a secreted inhibitor of Nodal and BMP
signaling, with an essential role in cardiac differentiation in
amphibians and ESC (Cai et al., 2013; Foley et al., 2007).
These studies suggest that cholesterol metabolites such as
the Gcrts may function much earlier in embryonic develop-
ment than previously anticipated and furthermore indicate
that Gcrts regulate the heart-inducing properties of the
anterior visceral endoderm.
Results and discussion
Cholesterol-derived metabolites regulate
cardiac differentiation
Cholesterol is metabolized into a number of steroid hormone
classes, including testosterone, estrogen, mineralocortocoids
(Mnrt) and glucocorticoids (Gcrt) through a series of catalytic
steps, which are each regulated by a selective enzyme(Fig. 1A) (Han et al., 2014). Cyp17a1 is responsible for the
generation of testosterone and estrogen, while Cyp21a1 and
Cyp11b1 are essential for Mnrt and Gcrt production (Han
et al., 2014). Given their early expression in the visceral
endoderm (VE) (Bair and Mellon, 2004), we hypothesized that
cholesterol metabolites may have a role in early germ layer
specification. Since the VE is a crucial player in cardiac
development, we tested the contribution of the various
metabolites during cardiac differentiation in mESC. Through
siRNA-mediated knockdown of Cyp17a1, the production of
testosterone and estrogen would be blocked and through
knockdown of Cyp21a1 Gcrt and Mnrt would no longer be
synthetized. We therefore studied functional alteration of
these two genes during mesoderm formation and patterning
in mESC, a stage equivalent to the expression of Cyp17a1 and
Cyp21a1 in the embryo. When introduced in mESC at day 3 of
spontaneous differentiation in serum (an assay with minimal
cardiac differentiation to allow a larger dynamic range),
the siRNA to Cyp17a1 increased cardiac differentiation as
observed with the cardiac specific Myh6-GFP mESC reporter
cell line, suggesting that increased Mnrt and Gcrt production
promotes cardiac differentiation (Figs. 1B, C). Indeed,
knockdown of Cyp21a1, the enzyme responsible for Mnrt
and Gcrt production, reduced cardiac differentiation signif-
icantly (Figs. 1B, C). We then treated serum-differentiated
mESC with Aldosterone (Ald, a Mnrt) and Dexamethasone
(Dex, a synthetic Gcrt) to confirm the contribution of
both steroid classes to cardiac differentiation, and as
predicted by the siRNA data, both Ald and Dex promoted
cardiac differentiation (Fig. 1D) when added at day 3 of
differentiation.
As previous studies had shown expression of the Gcrt
receptor Nr3c1 in the early embryo (Korgun et al., 2003), we
confirmed that Nr3c1 is indeed ubiquitously expressed in the
gastrulating mouse embryo (Fig. 1E), indicating an important
role for Gcrt at this time. Intriguingly, Nr3c1 is exclusively
localized in the nuclei of cells in the outermost cell layer of
the embryo, which corresponds to the visceral endoderm
(Fig. 1E). Nuclear receptors such as Nr3c1 translocate to the
nucleus when bound by their ligand (Kadmiel and Cidlowski,
2013; Newton, 2000), and, therefore, nuclear localization
suggested that Nr3c1 was exclusively active in the VE during
gastrulation. We thus returned to mESCs as a simplified
model of the developing embryo to further study the role of
Gcrt signaling during gastrulation stages.
In mESC cultures, Nr3c1 mRNA is most abundantly
expressed between days 2 and 4 of differentiation, which
corresponds to Nr3c1 expression in E6.5–7.5 stages of the
embryo when germ layers segregate and early cell fate is
specified (Fig. 1F) (Murry and Keller, 2008). Also equivalent
to the embryo, Nr3c1 mRNA expression was broadly
detectable in mesoderm, endoderm and ectoderm popula-
tions, which were FACS sorted from day 5 differentiating
mESC cultures (Fig. 1G, Supp Fig. 1A) (Cai et al., 2013;
Morrison et al., 2008; Nelson et al., 2008). Given the
expression pattern of Nr3c1 in differentiating mESC, we
then performed a wider Dex exposure series over time to
delineate the precise time window for cardiac induction.
RT-qPCR analysis for the cardiac markers Myh6 and Tnnt2
clearly demonstrates that Dex is most active between days 3
and 6 of differentiation (Fig. 1H). Dex drives an increase in
cardiomyocyte purity but does not affect the relative
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Figure 1 Cholesterol derivatives control cardiac differentiation in mESC. (A) Schematic representation of the key steps of
cholesterol metabolism that result in the production of testosterone, estrogens, mineralocorticoids (Mnrt) and glucocorticoids (Gcrt).
Enzymes required for the sub-steps are indicated in red boxes. (B–C)Myh6-GFP expression level (GFP density multiplied by area, DxA)
and Myh6-GFP flow cytometry analysis, respectively, at day 15 of differentiation after introduction of the indicated siRNAs at day 3 of
differentiation. (D) Myh6-GFP expression level (GFP density multiplied by area, DxA) at day 15 of differentiation after treatment with
DMSO, Dexamethasone (Dex) or Aldosterone (Ald) at day 3 of differentiation. (E) Nr3c1 protein is expressed ubiquitously in E6.5–E7
mouse embryos. White arrows indicate nuclear expression of Nr3c1 in the outer visceral endoderm layer. (F) Nr3c1 gene expression
time course in mESC spontaneously differentiated in serum-containing medium, quantified by RT-qPCR. (G) RT-qPCR analysis for
Nr3c1 expression in sorted mESC-derived day 5 populations including mesoderm (Flk1+/Cxcr4−), endoderm (Flk1−/Cxcr4+), ectoderm
(Flk1−/Cxcr4−) and cardiogenic mesoderm (Flk1+/Cxcr4+) (Cai et al., 2013; Morrison et al., 2008; Nelson et al., 2008). (H) RT-qPCR
analysis for cardiac genes Myh6 and Tnnt2 of day 12 ESC cultures differentiated in serum. Dexamethasone (Dex) treatment was given
at the indicated time windows. (I) Representative images of Myh6-GFP reporter activity on day 15 of differentiation after treatment
with indicated molecules at day 3 and image-based quantification of Myh6-GFP GFP density multiplied by area (DxA). (J–K) Myh6-GFP
and Cd31 flow cytometry analysis of day 15 cultures treated with Dex at day 3 of differentiation, respectively. (L) RT-qPCR analysis of
cardiovascular markers on day 15 samples after treatment with different doses of Dex. Asterisk indicates p b 0.05 relative to
controls.
90 J. Cabral-Teixeira et al.percentage of endothelial cells, suggesting that its effect is
cardiac specific (Fig. 1I–K, Supp Fig. 2A). RT-qPCR analysis
confirmed these findings, demonstrating that cardiac fate
was clearly induced in a concentration dependent manner
(Tnnt2 and Myh6) (Fig. 1L). Endothelial marker (Cd31 andCdh5) expression decreased slightly, but is most likely of
limited significance as the abundance of endothelial cells in
the cultures was low (b0.3%) (Fig. 1K). Furthermore, Dex
did not affect gene expression of hematopoietic (Runx1) or
smooth muscle lineage markers (Acta2) (Fig. 1L). Together,
91Glucocorticoids control cell fatethese data indicate that the cholesterol-derived Gcrts are
able to specifically control cardiac differentiation from
mouse ESC.
Glucocorticoids drive Cer1 expression in visceral
endoderm cells
To probe the underlying mechanism of cardiac differentia-
tion by Gcrts, we stimulated Gcrt signaling with Dex at day 30.0
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48 h of treatment, RT-qPCR analysis of fate specific markers
revealed no effect on mesoderm (Gsc, T/Brach, Gata4 or Evx1)
or definitive endoderm (Tspan7, Sox17, Cxcr4 or Foxa2),
suggesting that Gcrt signaling is not involved in early germ
layer specification (Figs. 2A, B). Since nuclear expression of
Nr3c1 in the VE of the mouse embryo indicated local Gcrt
activity,we profiled genes known to be expressed in the VE. Dex
upregulated Cer1, encoding a dual Nodal/BMP antagonist (Belo
et al., 2000), and Hnf4a, which is directly regulated by Gcrt0 
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92 J. Cabral-Teixeira et al.through response elements in its promoter (Bailly et al., 2001)
(Figs. 2C, D). In contrast, general VE markers (Bmp6, Emp2,
Rhox5, Hhex, Lefty1 and Sfrp1) were unaffected, suggesting
that Gcrts do not regulate VE fate per se, but play a selective
role within the VE (Figs. 2C, D). Indeed, siRNAs against Nr3c1
revealed that it is required for Dex to induce Cer1 (Fig. 2E).
Furthermore, siRNA knockdown ofHnf4a demonstrated that it is
needed for Dex to induce Cer1 (Fig. 2E), exposing a cascade
from Dex to Cer1, involving Nr3c1 and Hnf4a.
We then asked if endogenous Gcrt signalingwas also involved
in the induction of Cer1 expression by treating differentiating
mESC cultures with Etomidate (Eto), a Gcrt production inhibitor
that prevents activity of Cyp11b1, a key enzyme in Gcrt
production (Wagner et al., 1984; Zolle et al., 2008). Eto (10μM)
given at day 3 exclusively blocked Cer1 expression, but did not
affect other VE markers (Fig. 2F). Moreover, siRNA knockdown
of Hnf4a or Nr3c1 decreased Cer1 mRNA in the absence of Dex
(Supp Fig. 1B). Together, these findings implicate Gcrt signaling
in the developmental regulation of Cer1.
Gcrt or Dex might induce Cer1 via Hnf4a either within the
same cell or cell-non-autonomously through paracrine interac-
tions. To resolve these possibilities, we examined co-expression
of Nr3c1, Hnf4a and Cer1 in differentiating mESC cultures. As in
embryos, most cells of differentiation day 5 mESC cultures
express Nr3c1, andHnf4a-positive cell clusters are apparent in a
subset of Nr3c1 expressing cells (Fig. 2G). At higher magnifica-
tion, Cer1 is observed only in Hnf4a-positive cells (Fig. 2H),
suggesting that Cer1 is only expressed in VE cells marked by
Hnf4a. Indeed, if a non-VE specific mechanism were to exist,
every cell expressing Nr3c1 would upregulate Cer1 under
Dex-treated conditions, which is not the case (Figs. 2G, H). In
addition, sorting of endoderm cells from mESC cultures further
illustrates that Hnf4a and Cer1 are co-expressed in the same
cell population (Supp Fig. 1A, C). Importantly, in E6.5–E7.5
embryos, Cer1 and Hnf4a are co-expressed in the VE cells that
have Nr3c1 localized to the nucleus (Figs. 2I–K). Therefore, we
conclude that Gcrt signaling may act cell-autonomously within
the VE to regulate the production of the secreted antagonist
Cer1.Glucocorticoid signaling controls cell fate specification
through Hnf4a and Cer1
The VE, and more specifically the anterior portion of the
VE (aVE), is an important organizing center during early
embryogenesis in mammals that patterns anterior structures
(Arai et al., 1997; Kimura et al., 2000; Perea-Gomez et al.,
2002; Perea-Gomez et al., 2001). Meticulous removal of the aVE
in the mouse or its equivalent in chick (Hensen's node) or
amphibians (Organizer) prevents heart induction, illustrating
the importance for the aVE in cell fate specification (Arai et al.,
1997; Nascone and Mercola, 1995; Schultheiss et al., 1995).
Since Gcrt appears to be active in the VE, we tested
involvement of Hnf4a and Cer1 in cardiac differentiation
downstream of Gcrt. We transfected siRNAs or infected shRNAs
for each component, establishing that a Nr3c1–Hnf4a–Cer1
cascade mediates the pro-cardiac effect of Dex (Fig. 3A; Supp
Fig. 3A–C). We then asked if the Nr3c1–Hnf4a–Cer1 cascade
was required for cardiac differentiation in serum-free embryoid
body-based mESC cultures in the absence of Dex.
siRNA-mediated knockdown of Nr3c1, Hnf4a or Cer1 effectivelyblocked cardiac differentiation in this setting, suggesting that
endogenous Gcrt signaling is involved in specifying cardiac fate
(Figs. 3B–C, Supp Fig. 2B).
We thus far established that cardiac differentiation induced
by Dex is controlled by visceral endoderm factors, which
suggests that Dex is driving a cell non-autonomous effect on
cardiac differentiation through the endoderm. As discussed
above (see Fig. 2), our results indeed suggest that Dex is only
acting on a small number of endoderm cells. To confirm that
paracrine signaling from the endoderm may be responsible for
the cardiac effect of Gcrt signaling, we studied the effects of
modulation of Gcrt signaling in cultures that had limited
endoderm formation in comparison with endoderm-containing
cultures. Through titration of Activin A during day 2 to day 4 of
differentiation, cultures can be enriched for endoderm or
mesoderm, using high and low Activin A concentrations
respectively (D'amour et al., 2005; Gadue et al., 2006). Indeed,
cultures exposed to 15 ng/ml Activin A, and thus endoderm
enriched (Supp Fig. 3D), yield less mesoderm derivatives than
cultures exposed to 2 ng/ml Activin A (siCon histogram bars,
Fig. 3D), as indicated by the 5-fold difference in cardiomyocyte
abundance. Under endoderm-enriched conditions, individual
components of the Gcrt–Nr3c1–Hnf4a–Cer1 cascade are each
required for cardiomyocyte differentiation (AA15, Fig. 3D). In
contrast, cardiomyocyte differentiation is significantly less
sensitive to siRNA-mediated knockdown of Nr3c1, Hnf4a and
Cer1 when mES cells are differentiated towards mesoderm at
the expense of endoderm (AA2, Fig. 3D). Furthermore, Dex and
Eto respectively increased and suppressed cardiomyocyte
induction only under endoderm-enriched conditions (Fig. 3E).
These findings demonstrate that the need of Gcrt signaling for
cardiac fate is lost when endoderm is replaced by mesoderm;
thus implying that Gcrts are driving cardiac fate through a
paracrine mechanism in the endoderm.
These studies are the first demonstration that cholesterol
derivatives such as glucocorticoids regulate cell fate during very
early development. Our data support the model that Gcrt
signaling occurs in the VE of E6.5–E7 embryos, inducing Hnf4a,
which then drives Cer1 expression. Cer1 then controls cardiac
fate through the chromatin remodeling protein Baf60c by
titrating Nodal signaling (Fig. 4) (Cai et al., 2013). Although
neither the Nr3c1 nor Cer1 homozygous null transgenic mice
have a clear cardiac phenotype in vivo (Belo et al., 2000; Cole et
al., 1995), our findings suggest that Gcrt signaling in the aVE
might nonetheless play an important role in development. It is
well established that the aVE is essential to induce the neural
plate (Perea-Gomez et al., 2002) and heart (Arai et al., 1997;
Nascone and Mercola, 1995; Schultheiss et al., 1995), and the
absence of a pronounced effect in the null mice may be
explained by the following two reasons. First, the promiscuity
between Gcrt and Mnrt and their receptors should be
considered when assessing the importance of Nr3c1 in vivo
function during early development (Hellal-Levy et al., 1999;
Rogerson et al., 1999; Yoshikawa et al., 2002), and may thus
explain why Nr3c1−/− mutants are viable with no evident
cardiac defect. Indeed, we did observe that Mnrt signaling also
promotes cardiac differentiation. Further investigation of the
role of Mnrt signaling is however needed to understand howGcrt
and Mnrt may interact during cardiac differentiation in ESC.
Second, compensation or redundancy with Lefty1 might rescue
the Cer1 null embryos. Lefty1 is under-expressed during
mesoderm formation in mESCs as compared to embryos (Cai et
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Figure 3 Gcrt signaling activity in the visceral endoderm promotes cardiac fate. (A) Day 12 image-based analysis of the Myh6-GFP
reporter in mESC differentiation in serum in the presence of Dex and/or siRNA from day 3 of differentiation. (B–C) Flow cytometry
analysis of Myh6-GFP and Cd31 and RT-qPCR analysis, respectively, in serum-free differentiation day 15 cultures exposed to 15 ng/ml
Activin A (AA) at day 2 and siRNA at day 3. (D) Flow cytometry analysis of Myh6-GFP in serum-free differentiation day 15 cultures, with
Activin A (AA) titration at day 2 as indicated and siRNA introduced at day 3. (E) Image-based analysis of Myh6-GFP in serum-free
differentiation day 15 cultures, with Activin A titration at day 2 as indicated and small molecules introduced at day 3. Asterisk
indicates p b 0.05 relative to controls.
93Glucocorticoids control cell fateal., 2013), suggesting that Lefty1 might compensate for the loss
of Cer1 in the in vivo situation. Interestingly, double homozy-
gous Lefty1/Cer1 null mice have defective neural plate and
heart development (Perea-Gomez et al., 2002), suggestive of
mutual compensation possibly driven by feedback from high
Nodal/Activin signaling on Cer1 (Supp Fig. 3D). Gcrts do not
induce Lefty1; thus, the Gcrt–Nr3c1–Hnf4a–Cer1 and Nodal/
Lefty1 cascades may exist as mutually reinforcing mechanisms
to fine-tune Nodal signaling to correctly specify anterior cell
fates including the heart. An implication of our study is that
altered Gcrt and possibly Mnrt signaling could affect heart
formation during embryonic development in utero.
Materials and methods
More detailed materials and methods are made available as
supplementary information.
Mouse ESC culture and differentiation
CGR8 mouse ESC were maintained on gelatin-coated dishes
with leukemia inhibitory factor (LIF, Millipore). In the
presence of serum, cells were differentiated as described
previously (Willems et al., 2012). Dexamethasone (Sigma),
Aldosterone (Sigma) or Etomidate (Sigma) was added at day
3 or as indicated. siRNAs (Ambion) were transfected at day3 of differentiation using Lipofectamine RNAiMax (Life
Technologies) (Supp Fig. 4).
Serum-free differentiation was performed through an
embryoid body (EB) step. At day 2, EB were dissociated and
reaggregated in the presence of growth factors to specify
particular lineages. Activin A (R&D Systems) and BMP4 (R&D
Systems) were titrated depending on the fate choice (see
supplementary information). At day 3, EB were dissociated
again, and plated in the presence of siRNA and lipofectamine
RNAiMax or small molecules. Assays were then continued
with Activin A and BMP4. At day 5 media was replaced with
media containing IWR1 analogs (Lanier et al., 2012; Willems
et al., 2011).
Samples were processed as indicated for RT-qPCR, flow
cytometry or high content imaging. For high content
imaging, plates were loaded onto an automated microscope
(Incell 1000, GE Healthcare) and images were processed
using Cyteseer (Vala Sciences Inc.). GFP reads are represented
as the GFP area (A) multiplied by the GFP intensity (D).Immunostaining on embryos and cells
Decidua containing embryos at day E6.5 through E7.5 were
dissected and flash frozen prior to cryosectioning. Slides
were stained as described in supplement. Images were
acquired on a LSM510 Zeiss confocal microscope. Cells from
Cer1 Nkx2.5
Baf60c
Gastrulating mammalian embryo
D
A
Pr
P
Gcrt
Legend:
Visceral Endoderm
Anterior Visceral Endoderm
Mesoderm
Epiblast
Cardiomyocytes
Hnf4a
Nr3c1
Gcrt
Cer1 Cer1
Figure 4 Gcrt regulates Cer1 in the visceral endoderm to control cardiac fate in the underlying mesoderm. Proposed model of Gcrt
activity in cell fate specification during early embryogenesis based on mESC findings. A, anterior; D, distal; P, posterior; Pr, proximal.
94 J. Cabral-Teixeira et al.differentiation cultures were processed similarly after
fixation in paraformaldehyde.Flow cytometry and cell sorting
Cells were dissociated to single cell suspensions and analyzed on
a FACSCanto or LSRFortessa (BD Biosciences) for eGFP under
control of the Myh6 promoter. For extracellular staining, cells
were incubated for 30 min with antibodies as listed in the
supplement. Prior to analysis, cells were incubated with
propidium iodide (PI) to label non-viable cells. Data analysis
was performed using FlowJo (Treestar). Measured events were
gated for PI negative populations (exclusion of dead cells) and/
or forward/side scatter (exclusion of debris and aggregates)
before producing histograms or dot plots. Samples for sorting
where processed similarly and were run on a FACS Vantage-Diva
sorter (BD Biosciences).RNA extraction and RT-qPCR
RT-qPCR was performed following MIQE guidelines as described
in supplement (Bustin et al., 2009). Briefly, RNA was extracted
with Trizol and reverse transcribed with the Quantitect RT kit
(Qiagen) according to the included instructions. qPCR reactions
were run on an ABI 7900 (Life Technologies) using iTaq Universal
Sybr Green Master mix (Bio-Rad). Primer sequences are made
available in the RTPrimerDB (http://www.rtprimerdb.org/)
(Pattyn et al., 2003) and primer ID numbers are listed in
Supplementary Table 1. RT-qPCR data was standardized and
analyzed before statistical analysis as described previously
(Willems et al., 2008).Statistical analysis
All experiments were analyzed in at least three biological
replicates and were tested for significance by a Student's
t-test. Data in the figure is represented as mean with
error bars indicating SEM, with asterisks indicating a
p-value b 0.05.
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